News | June 29, 2025
Torrent Pharma to acquire KKR’s stake in JB Pharma for Rs. 25,689 Cr
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
The CR Bio unit represents a non-core legacy asset with limited strategic alignment to our core CDMO operations
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
This project builds on a previous joint funding agreement between CARBOGEN AMCIS and the same customer in April 2021
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
Akums invested Rs. 272 crore in capital expenditure during FY25
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
The CDMO upgrade represents a transformational step for Remedium Lifecare
Net Profit increased by 15% to Rs. 146 crores in Q4 FY25 and 19% to Rs. 660 crores in FY25
The company has posted net profit of Rs. 91.13 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
